Lung Cancer,SCLC (Small Cell Lung Cancer) Tarlatamab + PD-L1 Inhibitor as 1LM in ES-SCLC: DeLLphi-303 Sep 11, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Efficacy of Lazertinib vs Osimertinib in 1L EGFR NSCLC Sep 11, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Pre- and On-Treatment Immune Mediators in NSCLC ICI Therapy Sep 10, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) FBXO33 Enhances Myc Degradation and Reduces NSCLC Stemness Sep 10, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Enhanced NSCLC Mutation Detection via cfDNA & cfRNA Dual Analysis Sep 10, 2024
Lung Cancer,SCLC (Small Cell Lung Cancer) I-DXd Demonstrates Efficacy in ES-SCLC: IDeate-Lung01 Trial Sep 10, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab Plus Lazertinib Shows Improved PFS vs Osimertinib Sep 10, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Neoadjuvant Durvalumab Plus Novel Agents in NSCLC Sep 10, 2024
